Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

[Cost-effectiveness of lung volume reduction coil treatment in emphysema. STIC REVOLENS].

Deslee G, Barbe C, Bourdin A, Durand-Zaleski I, Dutau H, Jolly D, Jounieaux V, Kessler R, Mal H, Pison C, Thiberville L, Vergnon JM, Marquette CH.

Rev Mal Respir. 2012 Nov;29(9):1157-64. doi: 10.1016/j.rmr.2012.09.010. Epub 2012 Oct 12. French.

PMID:
23200592
2.

Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial.

Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Thiberville L, Leroy S, Marceau A, Laroumagne S, Mallet JP, Dukic S, Barbe C, Bulsei J, Jolly D, Durand-Zaleski I, Marquette CH; REVOLENS Study Group.

JAMA. 2016 Jan 12;315(2):175-84. doi: 10.1001/jama.2015.17821.

PMID:
26757466
3.

Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema.

Ramsey SD, Berry K, Etzioni R, Kaplan RM, Sullivan SD, Wood DE; National Emphysema Treatment Trial Research Group.

N Engl J Med. 2003 May 22;348(21):2092-102. Epub 2003 May 20.

4.

Effectiveness of endobronchial coil treatment for lung volume reduction in patients with severe heterogeneous emphysema and bilateral incomplete fissures: a six-month follow-up.

Kontogianni K, Gerovasili V, Gompelmann D, Schuhmann M, Heussel CP, Herth FJ, Eberhardt R.

Respiration. 2014;88(1):52-60. doi: 10.1159/000358441. Epub 2014 May 10.

PMID:
24819548
5.

A randomized clinical trial of lung volume reduction surgery versus best medical care for patients with advanced emphysema: a two-year study from Canada.

Miller JD, Malthaner RA, Goldsmith CH, Goeree R, Higgins D, Cox PG, Tan L, Road JD; Canadian Lung Volume Reduction Surgery Study.

Ann Thorac Surg. 2006 Jan;81(1):314-20; discussion 320-1.

PMID:
16368389
6.

Lung volume reduction coil treatment in chronic obstructive pulmonary disease patients with homogeneous emphysema: a prospective feasibility trial.

Klooster K, Ten Hacken NH, Franz I, Kerstjens HA, van Rikxoort EM, Slebos DJ.

Respiration. 2014;88(2):116-25. doi: 10.1159/000362522. Epub 2014 May 28.

7.

Economic analysis of lung volume reduction surgery as part of the National Emphysema Treatment Trial. NETT Research Group.

Ramsey SD, Sullivan SD, Kaplan RM, Wood DE, Chiang YP, Wagner JL.

Ann Thorac Surg. 2001 Mar;71(3):995-1002.

PMID:
11269488
8.

National Emphysema Treatment Trial redux: accentuating the positive.

Sanchez PG, Kucharczuk JC, Su S, Kaiser LR, Cooper JD.

J Thorac Cardiovasc Surg. 2010 Sep;140(3):564-72. doi: 10.1016/j.jtcvs.2010.03.050.

9.

Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction.

Strange C, Herth FJ, Kovitz KL, McLennan G, Ernst A, Goldin J, Noppen M, Criner GJ, Sciurba FC; VENT Study Group.

BMC Pulm Med. 2007 Jul 3;7:10.

10.

Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial.

Shah PL, Zoumot Z, Singh S, Bicknell SR, Ross ET, Quiring J, Hopkinson NS, Kemp SV; RESET trial Study Group.

Lancet Respir Med. 2013 May;1(3):233-40. doi: 10.1016/S2213-2600(13)70047-X. Epub 2013 Apr 23.

PMID:
24429129
11.

Mortality and functional performance in severe emphysema after lung volume reduction or transplant.

Weinstein MS, Martin UJ, Crookshank AD, Chatila W, Vance GB, Gaughan JP, Furukawa S, Criner GJ.

COPD. 2007 Mar;4(1):15-22.

PMID:
17364673
12.

Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema.

Slebos DJ, Klooster K, Ernst A, Herth FJ, Kerstjens HA.

Chest. 2012 Sep;142(3):574-82.

PMID:
22116796
13.

Persistent benefit from lung volume reduction surgery in patients with homogeneous emphysema.

Weder W, Tutic M, Lardinois D, Jungraithmayr W, Hillinger S, Russi EW, Bloch KE.

Ann Thorac Surg. 2009 Jan;87(1):229-36; discussion 236-7. doi: 10.1016/j.athoracsur.2008.10.012.

PMID:
19101303
14.

Early results of endoscopic lung volume reduction for emphysema.

Yim AP, Hwong TM, Lee TW, Li WW, Lam S, Yeung TK, Hui DS, Ko FW, Sihoe AD, Thung KH, Arifi AA.

J Thorac Cardiovasc Surg. 2004 Jun;127(6):1564-73.

15.

Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma.

Johansson G, Andreasson EB, Larsson PE, Vogelmeier CF.

Pharmacoeconomics. 2006;24(7):695-708. Erratum in: Pharmacoeconomics. 2008;26(10):894.

PMID:
16802845
16.

Biologic lung volume reduction in advanced upper lobe emphysema: phase 2 results.

Criner GJ, Pinto-Plata V, Strange C, Dransfield M, Gotfried M, Leeds W, McLennan G, Refaely Y, Tewari S, Krasna M, Celli B.

Am J Respir Crit Care Med. 2009 May 1;179(9):791-8. doi: 10.1164/rccm.200810-1639OC. Epub 2009 Jan 29.

PMID:
19179484
17.

Cost effectiveness of lung volume reduction surgery.

Ramsey SD.

Chest Surg Clin N Am. 2003 Nov;13(4):727-38, vii-viii. Review.

PMID:
14682605
18.

Long-term follow-up after bronchoscopic lung volume reduction treatment with coils in patients with severe emphysema.

Hartman JE, Klooster K, Gortzak K, ten Hacken NH, Slebos DJ.

Respirology. 2015 Feb;20(2):319-26. doi: 10.1111/resp.12435. Epub 2014 Nov 23.

19.

A forensic evaluation of the National Emphysema Treatment Trial using the expected value of information approach.

Ramsey SD, Blough DK, Sullivan SD.

Med Care. 2008 May;46(5):542-8. doi: 10.1097/MLR.0b013e318160b479.

PMID:
18438203
20.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
Items per page

Supplemental Content

Write to the Help Desk